Breast Cancer36m 42s
Clinical Challenges in Management of Hormone Receptor Positive -Her 2 Negative Advanced Breast Cancer (ABC)
The landscape of HR+ve/HER2-negative metastatic breast cancer (MBC) has evolved significantly with the introduction of newer treatment options such as CDK4/6 inhibitors, PI3K inhibitors, and selective estrogen receptor down regulators.
management of hr+/her2- breast cancer
cdk4/6 inhibitors
serds
pi3k inhibitors
biomarkers